EcoDrugPlus

Ribosomal Protein Lateral Stalk Subunit P1

Ensembl ID : ENSLBEG00000026469
Gene Symbol: RPLP1
3 Cross references
382 Possible Orthologues:

Selectin P

Ensembl ID : ENSLBEG00000018677
Gene Symbol: SELP
1 Cross references
49 Possible Orthologues:

Serine/threonine-Protein Kinase A-Raf-Like

Ensembl ID : ENSLBEG00000001185
Gene Symbol: LOC109994136
3 Cross references
191 Possible Orthologues:

Serine/threonine-Protein Kinase B-Raf-Like

Ensembl ID : ENSLBEG00000015105
Gene Symbol: LOC109976292
4 Cross references
217 Possible Orthologues:

Serine/threonine-Protein Kinase B-Raf-Like

Ensembl ID : ENSLBEG00000024273
Gene Symbol: LOC109992167
3 Cross references
217 Possible Orthologues:

Serine/threonine-Protein Kinase Chk2

Ensembl ID : ENSLBEG00000008900
Gene Symbol: LOC109995863
2 Cross references
205 Possible Orthologues:

Serine/threonine-Protein Kinase Pim-1-Like

Ensembl ID : ENSLBEG00000019813
Gene Symbol: LOC109985122
3 Cross references
246 Possible Orthologues:

Serpin Peptidase Inhibitor, Clade C (Antithrombin), Member 1

Ensembl ID : ENSLBEG00000002130
Gene Symbol: SERPINC1
1 Cross references
161 Possible Orthologues:

Serum Amyloid P-Component-Like

Ensembl ID : ENSLBEG00000005863
Gene Symbol: LOC109990005
2 Cross references
354 Possible Orthologues:

Si:dkey-211g8.6

Ensembl ID : ENSLBEG00000016040
Gene Symbol: SI:DKEY-211G8.6
1 Cross references
320 Possible Orthologues:

Sigma Non-Opioid Intracellular Receptor 1

Ensembl ID : ENSLBEG00000021385
Gene Symbol: SIGMAR1
3 Cross references
204 Possible Orthologues:

Sirtuin 1

Ensembl ID : ENSLBEG00000013216
Gene Symbol: SIRT1
3 Cross references
156 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).